Cargando…
What Prognostic Markers Should Be Evaluated in Marginal Zone Lymphoma? A Survey Among Leading International Experts
Supplemental Digital Content is available in the text.
Autores principales: | Bommier, Côme, Lambert, Jérôme, Nowakowski, Grzegorz, Zucca, Emanuele, Thieblemont, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806367/ https://www.ncbi.nlm.nih.gov/pubmed/35141471 http://dx.doi.org/10.1097/HS9.0000000000000680 |
Ejemplares similares
-
PB2073: LACK OF AGREEMENT ON EVENT-FREE SURVIVAL DEFINITION IN MARGINAL ZONE LYMPHOMA
por: Bommier, C., et al.
Publicado: (2022) -
Recent advances in understanding the biology of marginal zone lymphoma
por: Bertoni, Francesco, et al.
Publicado: (2018) -
Marginal zone lymphoma: present status and future perspectives
por: Cheah, Chan Y., et al.
Publicado: (2022) -
Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma
por: Quéro, Laurent, et al.
Publicado: (2021) -
Marginal zone lymphoma
por: Kimby, Eva
Publicado: (2018)